Aspectos da ecologia dos flebótomos do Parque Nacional da Serra dos Orgãos, Estado do Rio de Janeiro: V. Preferências alimentares (Diptera, Psychodidae, Phlebotominae)

Realizamos capturas simultâneas de flebótomos, no Parque Nacional da Serra dos Orgãos, Estado do Rio de Janeiro, utilizando três iscas: homem, gambá e galo. Em 298h capturamos 1.155 fêmeas de seis espécies do gênero Lutzomya. L. ayrozai e L. hirsuta foram as espécies mais numerosas; ambas sugaram somente próximo ao solo, sendo decididamente antropofílicas e mais ativas entre 17 e 24h. L. fischeri foi a espécie mais freqüente na copa e a que demonstrou maior ecletismo quanto ao hospedeiro, hora e local; na copa sugou mais o galo, especialmente entre 0 e 5h e, no solo, picou com maior intensidade o homem, principalmente entre 20 e 24h.

Phlébotomes de Bolivie: V. Lutzomyia brisolai n.sp., nouvelle espèce de phlébotome anthropophile de région subandine (Diptera, Psychodidae)

Les auteurs décrivent le mâle et la femelle d'une nouvelle espèce de phlébotome Lutzomyia brisolai n.sp., anthropophile, rencontrée dans plusieurs stations du piémont andin. Cette espèce, difficile à classer, présente des caractères l'apparentant à L. oliveirai et L. minasensis mais aussi aux espèces du sous-genre Nyssomyia.

V Jornada Tècnica de l’Arròs

En aquesta jornada de l’arròs, un any més, es donaran a conèixer els resultats més rellevants dels assajos realitzats durant la darrera campanya. Part dels treballs estan consolidats des de fa força temps, com serien els assajos de varietats i el control de malalties; mentre que d’altres resulten més novedosos, com seria el control biològic del chilo o l’aplicació de purins a l’arròs; d’altres ja porten algunes campanyes i serà força interessant fer balanç d’aquests treballs. Per finalitzar es farà una important reflexió sobre la situació actual dels fitosanitaris en el cultiu de l’arròs. És important que els assistents puguin debatre les diferents temàtiques abordades i, per tant, enriquir el contingut d’aquesta jornada. Aquesta jornada tècnica és fruit de l’esforç i la coordinació de tots els tècnics i institucions que es dediquen al conreu de l’arròs. Creiem que el contingut de la jornada els serà força interessant i assolirà les seves expectatives.

Effect of rufinamide on gating properties of voltage-gated sodium channel Na(v)1.7

Background: Voltage-gated sodium channels (Nav1.x) are important players in chronic pain. A particular interest has grown in Nav1.7, expressed in nociceptors, since mutations in its gene are associated to two inherited pain syndromes or insensitivity to pain. Rufinamide, a drug used to treat refractory epilepsy such as the Lennox-Gastaut syndrome, has been shown to reduce the number of action potentials in cortical neurons without completely blocking Na channels. Aim: The goal of this study was to investigate the effect of rufinamide on Nav1.7 current. Methods and results: Whole-cell patch clamp experiments were performed using HEK293 cells stably expressing Nav1.7. Rufinamide significantly decreased peak sodium current by 28.3, 21.2 and 12.5% at concentrations of 500, 100 and 50μM respectively (precise EC50 could not be calculated since higher rufinamide concentrations could not be achieved in physiological buffer solution). No significant difference on the V1/2 of voltage-dependence of activation was seen; however a shift in the steady-state inactivation curve was observed (-82.6 mV to -88.8 mV and -81.8 to -87.6 mV for 50 and 100 μM rufinamide respectively, p <0.005). Frequency-dependent inhibition of Nav1.7 was also influenced by the drug. One hundred μM rufinamide reduced the peak sodium current (in % of the peak current taken at the first sweep of a train of 50) from 90.8 to 80.8% (5Hz), 88.7 to 71.8% (10 Hz), 69.1 to 49.2% (25 Hz) and 22.3 to 9.8% (50 Hz) (all p <0.05). Onset of fast inactivation was not influenced by the drug since no difference in the time constant of current decay was observed. Conclusion: In the concentration range of plasma level in human treated for epilepsy, 15 μM, rufinamide only minimally blocks Nav1.7. However, it stabilizes the inactivated state and exerts frequencydependent inhibition of Nav1.7. These pharmacological properties may be of use in reducing ectopic discharges as a causal and symptom related contributor of neuropathic pain syndrome.

A new species of Dasybasis Macquart from NW of Argentina (Tabanidae, Diptera, Insecta)

Female and male of Dasybasis diaguita n. sp. from high area of NW of Argentina is described and illustrated.

Evolució del poblament i organització del territori a la Catalunya interior durant l'Antiguitat Tardana i l'Alta Edat Mitjana: els casos de la Catalunya Central (Bages, Berguedà i Solsonès) i la Garrotxa (segles V-X)

Projecte de recerca elaborat a partir d’una estada a la Université de Toulouse 2 – Le Mirail entre gener i juny del 2007. En concret, l’estada efectuada ha suposat la integració de qui signa aquesta memòria dins l’equip al-Andalus/Hispaniae, dirigit pel professor Philippe Sénac, una de les diverses branques que conformen el grup FRAMESPA d’aquella universitat, unitat de recerca adscrita al CNRS (UMR 5136). El títol proposat per al contingut de la recerca en la sol•licitud presentada, Evolució del poblament i organització del territori a la Catalunya interior a l’Alta Edat Mitjana, encapçalava un pla de treball que tenia per objectiu la recopilació i l’anàlisi de dades arqueològiques i textuals que oferissin un escenari a partir del qual establir una seqüència evolutiva en relació a les diferents tendències pel que fa al poblament tardoantic i altmedieval en dues zones diferenciades com són les conques mitjanes dels rius Llobregat i Cardener, a la Catalunya Central, i la capçalera del riu Fluvià, a la Garrotxa. Així, s’han pogut detectar, a partir de la contrastació de les diferents dades, fenòmens diversos que reflecteixen la incidència dels successius canvis històrics a nivell territorial i de poblament.

Reduced quality of life associated adverse events in intermediate hepatocellular carcinoma patients treated with PRECISION TACE with drug eluting beads: Results from the PRECISION V randomized trial : B-241

Purpose: To evaluate the extent of quality of life (QoL) associated adverse events (AEs) following PRECISION TACE with DC Bead compared with conventional transarterial chemoembolisation (cTACE). Methods and Materials: 201 intermediate HCC patients were treated with DC Bead (PRECISION TACE) or conventional TACE (cTACE) with doxorubicin in the PRECISION V clinical study. 93 patients were treated with DC Bead and 108 Patients with cTACE every 2 months and followed up for 6 months. AEs were classified according to the South West Oncology Group criteria. QoL associated AEs were defined as alopecia, constipation, nausea, vomiting, pyrexia, chills, asthenia, fatigue, and headache. Results: The biggest difference in QoL associated AEs was for alopecia: 2 patients (2.2%) for DC-Bead versus 21 patients (19.4%) for cTACE. For other clinical symptoms, constipation (n=10; 10.8% vs. n=13; 12%), vomiting (n=10; 10.8% vs. n=14; 13.0%), pyrexia (n=16; 17.2% vs. n=26; 24.1%), chills (n=1; 1.1% vs. n=5; 4.6%), and headache (n=2; 2.2% vs. n=8; 7.4%) showed lower incidence in the DC Bead group versus cTACE. Nausea, n= 15; 13.9% (n=15; 16.1%) and fatigue, n=6; 5.6% (n=13; 14.0%) were lower for cTACE. Total dose of doxorubicin was on average 35% higher in the DC Bead group. Conclusion: Although patients in the DC Bead group received a higher doxorubicin dose, less QoL associated AEs were reported for this group. Alopecia, the most obvious outward sign of toxicity, was only reported in a tenth of DC Bead patients. Thus, PRECISION TACE with DC Bead improves quality of life associated adverse events.